Intra-arterial plus i.v. chemotherapy for advanced bulky squamous cell carcinoma of the buccal mucosa

Anti-Cancer Drugs

Volumn 12, Issue 4, 2001, Pages 331-337

  Wang, Hung Ming ^a   Ng, Shu Hang ^a   Wang, Cheng Hsu ^a   Liaw, Chun Ta ^a   Chen, Jen Shi ^a   Yang, Tsai Shen ^a   Chen, I How ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DERMATITIS; HUMAN; LEUKOPENIA; MALE; MOUTH CARCINOMA; NAUSEA; NEPHROTOXICITY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; ALOPECIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; DRUG ERUPTIONS; DYSPNEA; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; LYMPHATIC METASTASIS; MALE; METHOTREXATE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; STOMATITIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035020226     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200104000-00005     Document Type: Article

References (31)

1. 1. Department of Health, Executive Yuan, ROC. Cancer Registry: Annual report in Taiwan area, 1995 [in Chinese]. 1998.
2. 2. Chong KM. Betel nut chewing and mouth cancer in Taiwan. Observation of the oral mucosa in the betel nut chewers. J Formosan Med Ass 1966; 65: 79-85.
3. 3. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: A preliminary report, J Formosan Med Ass 1976; 75: 497-505.
4. 4. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995; 24: 450-3.
5. 5. Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994; 86: 265-72.
6. 6. Wang HM, Wang CH, Chen JS, et al. CDDP and 5-FU as neoadjuvant chemotherapy: predicting response in head and neck squamous cell cancer, J Formosan Med Ass 1995; 94: 87-94.
7. 7. Menednhall WM, Parsons JT, Mancuso AA, Pameijer FJ, Stringer SP, Cassisi NJ. Definitve radiotherapy for T3 squamous cell carcinoma of the glottic larynx. J Clin Oncol 1997; 15: 2394-402.
8. 8. Van den Bogaert W, van der Schueren E, Horiot JC, et al, The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors. Radiother Oncol 1995; 35: 100-6.
9. 9. Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to the spontaneous mutation rate. Cancer Treat Rep 1979; 63: 1727-33.
10. 10, Johnson CR, Thames HD, Huang DT, Schmidt-Ullrich RK. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int J Radiol Oncol Biol Phys 1995; 33: 281-7.
11. 11. Cheung DK, Regan J, Savin M, Gibberman V, Woessner W, A pilot study of intra-arterial chemotherapy with CDDP in locally advanced head and neck cancer. Cancer 1988; 61: 903-8.
12. 12. Baker SR, Wheeler R. Intra-arterial chemotherapy for head and neck cancer, part 2: clinical experience. Head Neck Surg 1984; 6: 751-60.
13. 13. Frustaci S, Barzan L, Tumolo S, et al. Intra-arterial continuous infusion of cis-diamminodichloroplatinum in untreated head and neck cancer patients. Cancer 1986; 57: 1118-23.
14. 14. Baker SR, Forastiere AA, Wheeler R, Medvec BR. Intra-arterial chemotherapy for head and neck cancer. An update on the totally implantable Infusion pump. Arch Otolarygol Head Neck Surg 1987; 113: 1183-90.
15. 15. Wheeler RZ, Ziessman HA, Medvec BR, et al. Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer, Cancer Res 1986; 46: 4200-4.
16. 16. Million RR, Cassisi NJ, Mancuso AA, Stringer SP, Mendenhall WM, Parsons JT. Management of the neck for squamous cell carcinoma. In Million RR, Cassisi NJ, eds. Management of bead and neck cancer: a multidisciplinary approach, 2nd edn. Philadelphia, PA: Lippincott 1994: 75-142.
17. 17. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. American Joint Committee on Cancer: manual for staging of cancer, 4th edn. Philadelphia, PA: Lippincott 1992.
18. 18. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
19. 19. Forastiere AA, Baker SR, Wheeler R, Medvec BR. Intra-arterial CDDP and FUDR in advanced malignancies confined to the head and neck. J Clin Oncol 1987; 5: 1601-6.
20. 20. Wang HM, Wang CH, Chen JS, Su CL, Liao CT, Chen IH. Impact of oral submucosa fibrosis on chemotherapy-induced mucositis for head and neck cancer in a geographic area in which betel quid chewing is prevalent. Am J Clin Oncol 1999; 22: 485-8.
21. 21. Loffler T, Schulte-Mattler K, Huck L, et al. Levels of CDDP (DDP) in tumor tissue after intra-arterial and systemic chemotherapy. In: Proc Intra-arterial Intracavitary Chemotherapy Conf. 1984; 234.
22. 22. Stewart DJ, Benjamin RS, Zimmerman S, et al. Clinical pharmacology of intra-arterial cis-diamminedichloroplatinum (II). Cancer Res 1983; 43: 917-20.
23. 23. Forastiere AA, Takasugi BJ, Baker SR, et al. High-dose CDDP in advanced head and neck cancer. Cancer Chemother Pharmacol 1987; 19: 155-8.
24. 24. Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984; 2: 498-504.
25. 25. Ensminger WD. Intraarterial therapy. In: Perry MC, ed. The chemotherapy source book, 1st edn. Baltimore, MD: Williams & Wilkins 1992: 256-71.
26. 26. Claudio F, Cacace F, Comela G, et al. Intraarterial chemotherapy through carotid transposition in advanced head and neck cancer. Cancer 1990; 65: 1465-71.
27. 27. Baker SR, Wheeker RH. Intraarterial chemotherapy for head and neck cancer, part 1: theoretical consideration and drug delivery system. Head Neck Surg 1983; 6: 664-82.
28. 28. Helsper JT, DeMoss EV. Regional intraarterial Infusion of 5-fluorouracil for cancer. Surgery 1964; 56: 340-8.
29. 29. Frustaci S, Barzan L, Caruso G, et al. Induction intra-arterial cisplatin and bleomycin in head and neck cancer. Head & Neck 1991; 13: 291-7.
30. 30. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993; 85: 95-111.
31. 31. Jacobs C, Pinto H. Adjuvant and neoadjuvant treatment of head and neck cancers: the next chapter. Semin Oncol 1995; 22: 540-52.